Overexpression of the HER1 and/or HER2 receptors by breast tumours generally predicts poor patient prognosis (Slamon 1990; Witton et al, 2003; Abd El-Rehim et al, 2004; Wiseman et al, 2005), corresponding to our findings. The gene discussed is EGFR; the disease is breast neoplasm.